 , Anti-Estrogens , Antineoplastic Agents , Antineoplastic Agents, Hormonal , Antineoplastic and Immunomodulating Agents , BCRP/ABCG2 Substrates , Benzene Derivatives , Benzylidene Compounds , BSEP/ABCB11 Inhibitors , Cardiotoxic antineoplastic agents , Cytochrome P-450 CYP1A2 Substrates , Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2A6 Substrates , Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2B6 Inhibitors , Cytochrome P-450 CYP2B6 Inhibitors (moderate) , Cytochrome P-450 CYP2B6 Substrates , Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2C19 Substrates , Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2C8 Inhibitors , Cytochrome P-450 CYP2C8 Inhibitors (moderate) , Cytochrome P-450 CYP2C9 Inhibitors , Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) , Cytochrome P-450 CYP2C9 Substrates , Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2D6 Inhibitors , Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) , Cytochrome P-450 CYP2D6 Substrates , Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2E1 Substrates , Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A Inducers , Cytochrome P-450 CYP3A Inhibitors , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inducers , Cytochrome P-450 CYP3A4 Inducers (strength unknown) , Cytochrome P-450 CYP3A4 Inhibitors , Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A5 Substrates , Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A7 Substrates , Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 Enzyme Inducers , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Substrates , Endocrine Therapy , Estrogen Agonist/Antagonist , Estrogen Antagonists , Estrogen Receptor Modulators , Hormone Antagonists , Hormone Antagonists and Related Agents , Hormones, Hormone Substitutes, and Hormone Antagonists , Narrow Therapeutic Index Drugs , P-glycoprotein inducers , P-glycoprotein inhibitors , P-glycoprotein substrates , P-glycoprotein substrates with a Narrow Therapeutic Index , Potential QTc-Prolonging Agents , QTc Prolonging Agents , Selective Estrogen Receptor Modulators , Stilbenes , Thyroxine-binding globulin inducers , UGT2B17 substrates , UGT2B7 substrates , UGT2B7 Substrates with a Narrow Therapeutic Index